Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Zhongguo Zhong Yao Za Zhi ; 43(15): 3205-3210, 2018 Aug.
Article in Chinese | MEDLINE | ID: mdl-30200719

ABSTRACT

In recent years,hepatotoxicity problem of Polygonum multiflorum has caused high attention. Domestic scholars also explored the causes of liver damage caused by it. For example, the establishment of guideline for diagnosis and treatment of herb-induced liver injury, and the theory about relationship between hepatocyte toxicity and chemical composition, solvents, processing, use and pathological basis of patients and so on. To try to combine theory with practice,author analyzed risk factors about the case reports of P. multiflorum causing liver damage, and made some suggestions on P. multiflorum about individualized application, drug selection and requirements for taking. This for providing reference for the safe use of P. multiflorum.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Fallopia multiflora/chemistry , Hepatocytes/drug effects , Chemical and Drug Induced Liver Injury , Drugs, Chinese Herbal/toxicity , Fallopia multiflora/toxicity , Humans , Retrospective Studies , Risk Factors
2.
Neurotoxicology ; 64: 219-229, 2018 01.
Article in English | MEDLINE | ID: mdl-28651968

ABSTRACT

Excessive manganese (Mn) accumulation in the brain may induce an extrapyramidal disorder known as manganism. Inflammatory processes play a critical role in neurodegenerative diseases. Therapeutically, non-steroidal anti-inflammatory drugs or analogous anti-inflammatory therapies have neuroprotective effects. As a non-steroidal anti-inflammatory drug, p-aminosalicylic acid (PAS) has anti-inflammatory effects, which are mediated by decreased prostaglandins E2 (PGE2) levels. The aim of the current study was to investigate whether PAS-Na treatment prevents Mn-induced behavioral changes and neuroinflammation in vivo. Male Sprague-Dawley rats were intraperitoneally (i.p.) injected with MnCl2·4H2O (15mg/kg) for 12 weeks, followed by 6 weeks PAS-Na treatment. Sub-chronic Mn exposure increased Mn levels in the whole blood, cortex, hippocampus and thalamus, and induced learning and memory deficits, concomitant with astrocytes activation in the cortex, hippocampus and thalamus. Moreover inflammatory cytokine levels in serum and brain of Mn-treated group were increased, including IL-1ß, IL-6, TNF-αand PGE2, especially in the hippocampus and thalamus. Furthermore, sub-chronic Mn exposure also increased inflammatory cytokines and COX-2 in transcription levels concomitant with increased MAPK signaling and COX-2 in the same selected brain regions. PAS-Na treatment at the highest doses also decreased Mn levels in the whole blood and selected brain tissues, and reversed the Mn-induced learning and memory deficits. PAS-Na inhibited astrocyte activation as well as the Mn-induced increase in inflammatory cytokine levels, reducing p38, ERK MAPK pathway and COX-2 activity. In contrast PAS-Na had no effects on the JNK MAPK pathway. These data establish the efficacy of PAS-Na not only as a chelating agent to mobilize whole blood Mn, but also as an anti-inflammatory agent.


Subject(s)
Aminosalicylic Acid/administration & dosage , Cyclooxygenase 2/metabolism , Encephalitis/metabolism , Encephalitis/prevention & control , MAP Kinase Signaling System/drug effects , Manganese/toxicity , Neuroprotective Agents/administration & dosage , Animals , Brain/drug effects , Brain/metabolism , Encephalitis/chemically induced , Inflammation Mediators/metabolism , Male , Manganese/metabolism , Maze Learning/drug effects , Rats, Sprague-Dawley
3.
Article in English | MEDLINE | ID: mdl-28394286

ABSTRACT

Excessive manganese (Mn) exposure is not only a health risk for occupational workers, but also for the general population. Sodium para-aminosalicylic acid (PAS-Na) has been successfully used in the treatment of manganism, but the involved molecular mechanisms have yet to be determined. The present study aimed to investigate the effects of PAS-Na on sub-chronic Mn exposure-induced impairments of spatial learning and memory, and determine the possible involvements of γ-aminobutyric acid (GABA) metabolism in vivo. Sprague-Dawley male rats received daily intraperitoneal injections MnCl2 (as 6.55 mg/kg Mn body weight, five days per week for 12 weeks), followed by daily subcutaneous injections of 100, 200, or 300 mg/kg PAS-Na for an additional six weeks. Mn exposure significantly impaired spatial learning and memory ability, as noted in the Morris water maze test, and the following PAS-Na treatment successfully restored these adverse effects to levels indistinguishable from controls. Unexpectedly, PAS-Na failed to recover the Mn-induced decrease in the overall GABA levels, although PAS-Na treatment reversed Mn-induced alterations in the enzyme activities directly responsible for the synthesis and degradation of GABA (glutamate decarboxylase and GABA-transaminase, respectively). Moreover, Mn exposure caused an increase of GABA transporter 1 (GAT-1) and decrease of GABA A receptor (GABAA) in transcriptional levels, which could be reverted by the highest dose of 300 mg/kg PAS-Na treatment. In conclusion, the GABA metabolism was interrupted by sub-chronic Mn exposure. However, the PAS-Na treatment mediated protection from sub-chronic Mn exposure-induced neurotoxicity, which may not be dependent on the GABA metabolism.


Subject(s)
Aminosalicylic Acid/pharmacology , Manganese Poisoning/pathology , Manganese/toxicity , Memory/drug effects , Spatial Learning/drug effects , gamma-Aminobutyric Acid/blood , Animals , Drug Administration Schedule , Male , Random Allocation , Rats , Rats, Sprague-Dawley , gamma-Aminobutyric Acid/metabolism
4.
Biol Trace Elem Res ; 176(1): 143-153, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27491492

ABSTRACT

Excessive intake of manganese (Mn) may cause neurotoxicity. Sodium para-aminosalicylic acid (PAS-Na) has been used successfully in the treatment of Mn-induced neurotoxicity. The γ-aminobutyric acid (GABA) is related with learning and memory abilities. However, the mechanism of PAS-Na on improving Mn-induced behavioral deficits is unclear. The current study was aimed to investigate the effects of PAS-Na on Mn-induced behavioral deficits and the involvement of ultrastructural alterations and γ-aminobutyric acid (GABA) metabolism in the basal ganglia of rats. Sprague-Dawley rats received daily intraperitoneally injections of 15 mg/kg MnCl2.4H2O, 5d/week for 4 weeks, followed by a daily back subcutaneously (sc.) dose of PAS-Na (100 and 200 mg/kg), 5 days/week for another 3 or 6 weeks. Mn exposure for 4 weeks and then ceased Mn exposure for 3 or 6 weeks impaired spatial learning and memory abilities, and these effects were long-lasting. Moreover, Mn exposure caused ultrastructural alterations in the basal ganglia expressed as swollen neuronal with increasing the electron density in the protrusions structure and fuzzed the interval of neuropil, together with swollen, focal hyperplasia, and hypertrophy of astrocytes. Additionally, the results also indicated that Mn exposure increased Glu/GABA values as by feedback loops controlling GAT-1, GABAA mRNA and GABAA protein expression through decreasing GABA transporter 1(GAT-1) and GABA A receptor (GABAA) mRNA expression, and increasing GABAA protein expression in the basal ganglia. But Mn exposure had no effects on GAT-1 protein expression. PAS-Na treatment for 3 or 6 weeks effectively restored the above-mentioned adverse effects induced by Mn. In conclusion, these findings suggest the involvement of GABA metabolism and ultrastructural alterations of basal ganglia in PAS-Na's protective effects on the spatial learning and memory abilities.


Subject(s)
Aminosalicylic Acid/pharmacology , Basal Ganglia/drug effects , Manganese/pharmacology , Maze Learning/drug effects , Memory/drug effects , gamma-Aminobutyric Acid/metabolism , Animals , Astrocytes/drug effects , Astrocytes/metabolism , Astrocytes/ultrastructure , Basal Ganglia/metabolism , Basal Ganglia/ultrastructure , Blotting, Western , GABA Plasma Membrane Transport Proteins/genetics , GABA Plasma Membrane Transport Proteins/metabolism , Gene Expression/drug effects , Glutamic Acid/metabolism , Male , Maze Learning/physiology , Memory/physiology , Microscopy, Electron, Transmission , Neurons/drug effects , Neurons/metabolism , Neurons/ultrastructure , Neuropil/drug effects , Neuropil/metabolism , Neuropil/ultrastructure , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Time Factors
5.
J Toxicol Sci ; 41(5): 573-81, 2016.
Article in English | MEDLINE | ID: mdl-27665767

ABSTRACT

Sodium para-aminosalicylate (PAS-Na) was first applied successfully in clinical treatment of two manganism patients with good prognosis. However, the mechanism of how PAS-Na protects against Mn-induced neurotoxicity is still elusive. The current study was conducted to explore the effects of PAS-Na on Mn-induced basal ganglia astrocyte injury, and the involvement of amino acid neurotransmitter in vitro. Basal ganglia astrocytes were exposed to 500 µM manganese chloride (MnCl2) for 24 hr, following by 50, 150, or 450 µM PAS-Na treatment for another 24 hr. MnCl2 significantly decreased viability of astrocytes and induced DNA damages via increasing the percentage of tail DNA and Olive tail moment of DNA. Moreover, Mn interrupted amino acid neurotransmitters by decreasing Gln levels and increasing Glu, Gly levels. In contrast, PAS-Na treatment reversed the aforementioned Mn-induced toxic effects on basal ganglia astrocytes. Taken together, our results demonstrated that excessive Mn exposure may induce toxic effects on basal ganglia astrocytes, while PAS-Na could protect basal ganglia astrocytes from Mn-induced neurotoxicity.


Subject(s)
Aminosalicylic Acid/pharmacology , Astrocytes/drug effects , Basal Ganglia/drug effects , Chlorides/toxicity , DNA Damage/drug effects , Glutamic Acid/metabolism , Glutamine/metabolism , Glycine/metabolism , Manganese Poisoning/prevention & control , Protective Agents/pharmacology , Animals , Animals, Newborn , Astrocytes/metabolism , Astrocytes/pathology , Basal Ganglia/metabolism , Basal Ganglia/pathology , Cells, Cultured , Cytoprotection , Dose-Response Relationship, Drug , Manganese Compounds , Manganese Poisoning/genetics , Manganese Poisoning/metabolism , Manganese Poisoning/pathology , Rats, Sprague-Dawley
6.
J Trace Elem Med Biol ; 36: 84-9, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27259357

ABSTRACT

Manganese (Mn) overexposure induced neurological damages, which could be potentially protected by sodium para-aminosalicylic acid (PAS-Na). In this study, we systematically detected the changes of divalent metal elements in most of the organs and analyzed the distribution of the metals in Mn-exposed rats and the protection by PAS-Na. Sprague Dawley (SD) rats received intraperitoneal injections of 15mg/kg MnCl2·4H2O (5d/week for 3 weeks), followed by subcutaneous (back) injections of PAS-Na (100 and 200mg/kg, everyday for 5 weeks). The concentrations of Mn and other metal elements [Iron (Fe), Copper (Cu), Zinc (Zn), Magnesium (Mg), Calcium (Ca)] in major organs (liver, spleen, kidney, thighbone and iliac bone, cerebral cortex, hippocampus and testes) and blood by Inductively Coupled Plasma-Atomic Emission Spectrometry (ICP-AES). The results showed that Mn overexposure significantly increased Mn in most organs, Fe and Zn in liver, Fe and Mg in blood; however decreased Fe, Cu, Zn, Mg and Ca in cortex, Cu and Zn in kidney, Cu and Mg in iliac bone, and Zn in blood. In contrast, PAS-Na treatment restored most changes particularly in cortex. In conclusion, excessive Mn exposure disturbed the balance of other metal elements but PAS-Na post-treatments could restore these alterations.


Subject(s)
Aminosalicylic Acid/pharmacology , Manganese/metabolism , Manganese/pharmacology , Metals/metabolism , Aminosalicylic Acid/administration & dosage , Animals , Injections, Intraperitoneal , Injections, Subcutaneous , Male , Manganese/administration & dosage , Manganese/blood , Metals/blood , Rats , Rats, Sprague-Dawley
7.
Biol Trace Elem Res ; 170(2): 357-65, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26286965

ABSTRACT

Manganese (Mn), an essential trace metal for protein synthesis and particularly neurotransmitter metabolism, preferentially accumulates in basal ganglia. However, excessive Mn accumulation may cause neurotoxicity referred to as manganism. Sodium para-aminosalicylic acid (PAS-Na) has been used to treat manganism with unclear molecular mechanisms. Thus, we aim to explore whether PAS-Na can inhibit Mn-induced neuronal injury in basal ganglia in vitro. We exposed basal ganglia neurons with 50 µM manganese chloride (MnCl2) for 24 h and then replaced with 50, 150, and 450 µM PAS-Na treatment for another 24 h. MnCl2 significantly decreased cell viability but increased leakage rate of lactate dehydrogenase and DNA damage (as shown by increasing percentage of DNA tail and Olive tail moment). Mechanically, Mn reduced glutathione peroxidase and catalase activity and interrupted amino acid neurotransmitter balance. However, PAS-Na treatment reversed the aforementioned Mn-induced toxic effects. Taken together, these results showed that PAS-Na could protect basal ganglia neurons from Mn-induced neurotoxicity.


Subject(s)
Aminosalicylic Acid/pharmacology , Basal Ganglia/metabolism , Manganese Poisoning/metabolism , Manganese/toxicity , Neurons/metabolism , Neurotransmitter Agents/metabolism , Animals , Basal Ganglia/pathology , Cells, Cultured , Manganese Poisoning/pathology , Neurons/pathology , Oxidation-Reduction/drug effects , Primary Cell Culture , Rats , Rats, Sprague-Dawley
8.
Zhongguo Zhong Yao Za Zhi ; 40(8): 1594-600, 2015 Apr.
Article in Chinese | MEDLINE | ID: mdl-26281605

ABSTRACT

In China, many surveys have shown that most people do not have a correct understanding about cold and administration of anti-cold Chinese patent medicine preparations. The author conducted a systematic summary and analysis on the actual application of anti-cold Chinese patent medicine preparations as well as the warning on safe application of anti-cold Chinese patent medicine preparations in Clinical Medication Information of China Pharmacopoeia, in the expectation of reducing the blind application of anti-cold Chinese patent medicine preparations and providing traditional Chinese medicine pharmacists new ideas in monitoring the safe application of exterior syndrome-relieving Chinese patent medicine preparations.


Subject(s)
Common Cold/drug therapy , Drugs, Chinese Herbal/adverse effects , China , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/therapeutic use , Humans , Nonprescription Drugs/adverse effects , Nonprescription Drugs/chemistry , Nonprescription Drugs/therapeutic use
9.
Zhong Yao Cai ; 37(8): 1353-6, 2014 Aug.
Article in Chinese | MEDLINE | ID: mdl-25726640

ABSTRACT

OBJECTIVE: To study the microwave processing method of Achyranthis Bidentatae Radix processed with wine. METHODS: The content of total saponins, oleanolic acid and ß-ecdysterone were determined as the indices to get the optimal microwave processing technology by orthogonal design. RESULTS: The best technology of Achyranthis Bidentatae Radix processed with wine were:the amount of vinegar was 20%, moistening time was 60 min, with 60% microwave heating for 3 min. CONCLUSION: This method is simple, practical, scientific and easy to control.


Subject(s)
Microwaves , Drugs, Chinese Herbal/chemistry , Oleanolic Acid , Plant Roots , Saponins , Wine
SELECTION OF CITATIONS
SEARCH DETAIL
...